FDAFDA · Food and drugs·Recall number D-0659-2024
AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01
Published September 25, 2024 · Recall initiated: August 24, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ACETAZOLAMIDE
- Manufacturer
- Rubicon Research Private Limited
- Distributor
- Nationwide in the US
- UPC
- 0372888047010
- Lot
- Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- India
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.